EA
Ed Arce WestPark Capital Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Enanta Pharmaceuticals
ENTA
$189M
| $8.85 | $24 |
171%
upside
| Buy |
2 Sep ‘25
6 days ago |
|
2
Travere Therapeutics
TVTX
$1.93B
| $21.64 | $30 |
39%
upside
| Buy |
11 Jun ‘25
2 months ago |
|
|
MTVA
3
MetaVia Inc. Common Stock
MTVA
$16.7M
| $0.6899 | $12 |
1,639%
upside
| Buy |
16 Apr ‘25
4 months ago |
|
4
Unicycive Therapeutics
UNCY
$77M
| $4.36 | $75 |
1,620%
upside
| Buy |
11 Apr ‘25
5 months ago |
|
5
Arcturus Therapeutics
ARCT
$485M
| $17.85 | $60 |
236%
upside
| Buy |
10 Apr ‘25
5 months ago |
|
6
Akebia Therapeutics
AKBA
$785M
| $2.96 | $7.50 |
153%
upside
| Buy |
4 Apr ‘25
5 months ago |
|
|
IVA
7
Inventiva
IVA
$775M
| $5.57 | $13 |
133%
upside
| Buy |
2 Apr ‘25
5 months ago |
|
8
Talphera
TLPH
$11.3M
| $0.5492 | $6 |
993%
upside
| Buy |
1 Apr ‘25
5 months ago |
|
9
Aligos Therapeutics
ALGS
$78.8M
| $11.34 | $70 |
517%
upside
| Buy |
31 Mar ‘25
5 months ago |
|
10
Acurx Pharmaceuticals
ACXP
$6.47M
| $4.08 | $240 |
5,782%
upside
| Buy |
19 Mar ‘25
5 months ago |
|
11
Sagimet Biosciences
SGMT
$231M
| $7.11 | $32 |
350%
upside
| Buy |
13 Mar ‘25
5 months ago |
|
12
Cidara Therapeutics
CDTX
$1.6B
| $63.17 | $35 |
45%
downside
| Buy |
10 Mar ‘25
6 months ago |
|
13
Akero Therapeutics
AKRO
$3.58B
| $44.72 | $75 |
68%
upside
| Buy |
3 Mar ‘25
6 months ago |
|
14
89bio
ETNB
$1.32B
| $8.87 | $21 |
137%
upside
| Buy |
28 Feb ‘25
6 months ago |
|
15
Mirum Pharmaceuticals
MIRM
$3.82B
| $76.06 | $72 |
5%
downside
| Buy |
28 Feb ‘25
6 months ago |
|
16
Madrigal Pharmaceuticals
MDGL
$9.65B
| $432.89 | $405 |
6%
downside
| Buy |
27 Feb ‘25
6 months ago |
|
17
Ardelyx
ARDX
$1.57B
| $6.52 | $5.50 |
16%
downside
| Neutral |
21 Feb ‘25
6 months ago |
|
18
Ultragenyx Pharmaceutical
RARE
$3.07B
| $31.82 | $95 |
199%
upside
| Buy |
18 Feb ‘25
6 months ago |
|
|
19
Enanta Pharmaceuticals
ENTA
$189M
| $8.85 | $18 |
103%
upside
| Buy |
11 Feb ‘25
6 months ago |
|
|
GNFT
20
Genfit
GNFT
$197M
| $3.94 | $13 |
230%
upside
| Buy |
7 Feb ‘25
7 months ago |
|
21
Arbutus Biopharma
ABUS
$805M
| $4.20 | $5 |
19%
upside
| Buy |
21 Jan ‘25
7 months ago |
|
22
NewAmsterdam Pharma
NAMS
$3.04B
| $27 | $48 |
78%
upside
| Buy |
14 Jan ‘25
7 months ago |
|
23
Terns Pharmaceuticals
TERN
$632M
| $7.22 | $7.50 |
4%
upside
| Neutral |
4 Dec ‘24
9 months ago |
|
24
Iterum Therapeutics
ITRM
$30.3M
| $0.6782 | $5 |
637%
upside
| Buy |
10 Sep ‘24
1 year ago |
|
25
Aurinia Pharmaceuticals
AUPH
$1.63B
| $12.40 | $13 |
5%
upside
| Buy |
6 Sep ‘24
1 year ago |
|